TSHA - Taysha Gene Therapies  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TSHA is currently covered by 8 analysts with an average price target of $11.59. This is a potential upside of $8.72 (303.83%) from yesterday's end of day stock price of $2.87.

Taysha Gene Therapies 's activity chart (see below) currently has 50 price targets and 98 ratings on display. The stock rating distribution of TSHA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 18.44% with an average time for these price targets to be met of 84.31 days.

Highest price target for TSHA is $14, Lowest price target is $6, average price target is $8.

Most recent stock forecast was given by WHITNEY IJEM from CANACCORD on 13-Aug-2025. First documented stock forecast 19-Oct-2020.

Currently out of the existing stock ratings of TSHA, 43 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$14

$11.06 (376.19%)

$11

8 days ago
(13-Aug-2025)

0/7 (0%)

$10.97 (362.05%)

Buy

$8

$5.06 (172.11%)

$8

1 months 20 days ago
(01-Jul-2025)

0/21 (0%)

$5.66 (241.88%)

Buy

$6

$3.06 (104.08%)

$5

2 months 23 days ago
(29-May-2025)

2/10 (20%)

$3.25 (118.18%)

401

Buy

$9

$6.06 (206.12%)

$7

2 months 23 days ago
(29-May-2025)

0/7 (0%)

$6.25 (227.27%)

Buy

$7

$4.06 (138.10%)

$7

3 months 24 days ago
(28-Apr-2025)

1/12 (8.33%)

$5.2 (288.89%)

137

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TSHA (Taysha Gene Therapies ) average time for price targets to be met?

On average it took 84.31 days on average for the stock forecasts to be realized with a an average price target met ratio 18.44

Which analyst has the current highest performing score on TSHA (Taysha Gene Therapies ) with a proven track record?

SALVEEN RICHTER

Which analyst has the most public recommendations on TSHA (Taysha Gene Therapies )?

Salveen Richter works at GOLDMAN SACHS and has 8 price targets and 5 ratings on TSHA

Which analyst is the currently most bullish on TSHA (Taysha Gene Therapies )?

Whitney Ijem with highest potential upside - $11.06

Which analyst is the currently most reserved on TSHA (Taysha Gene Therapies )?

Gbola Amusa with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?